首站-论文投稿智能助手
典型文献
Endocrine aberrations of human nonobstructive azoospermia
文献摘要:
Nonobstructive azoospermia(NOA)refers to the failure of spermatogenesis,which affects approximately 1%of the male population and contributes to 10%of male infertility.NOA has an underlying basis of endocrine imbalances since proper human spermatogenesis relies on complex regulation and cooperation of multiple hormones.A better understanding of subtle hormonal disturbances in NOA would help design and improve hormone therapies with reduced risk in human fertility clinics.The purpose of this review is to summarize the research on the endocrinological aspects of NOA,especially the hormones involved in hypothalamic-pituitary-testis axis(HPTA),including gonadotropin-releasing hormone,follicle-stimulating hormone,luteinizing hormone,prolactin,testosterone,estradiol,sex hormone binding globulin,inhibin B,anti-Müllerian hormone,and leptin.For the NOA men associated with primary testicular failure,the quality of currently available evidence has not been sufficient enough to recommend any general hormone optimization therapy.Some other NOA patients,especially those with hypogonadotropic hypogonadism,could be treated with hormonal replacement.Although these approaches have succeeded in resuming the fertility in many NOA patients,the prudent strategies should be applied in individuals according to specific NOA etiology by balancing fertility benefits and potential risks.This review also discusses how NOA can be induced by immunization against hormones.
文献关键词:
作者姓名:
Yong Tao
作者机构:
Ottawa Fertility Center,955 Green Valley Crescent,Ottawa,ON K2C 3V4,Canada
引用格式:
[1]Yong Tao-.Endocrine aberrations of human nonobstructive azoospermia)[J].亚洲男性学杂志(英文版),2022(03):274-286
A类:
nonobstructive,Nonobstructive,HPTA
B类:
Endocrine,aberrations,human,azoospermia,NOA,refers,failure,spermatogenesis,which,affects,approximately,male,population,contributes,infertility,has,underlying,basis,endocrine,imbalances,since,proper,relies,complex,regulation,cooperation,multiple,hormones,better,understanding,subtle,hormonal,disturbances,would,help,design,improve,therapies,reduced,clinics,purpose,this,review,summarize,research,endocrinological,aspects,especially,involved,hypothalamic,pituitary,testis,axis,including,gonadotropin,releasing,follicle,stimulating,luteinizing,prolactin,testosterone,estradiol,sex,binding,globulin,inhibin,anti,llerian,leptin,For,associated,primary,testicular,quality,currently,available,evidence,not,been,sufficient,enough,recommend,general,optimization,therapy,Some,other,patients,those,hypogonadotropic,hypogonadism,could,treated,replacement,Although,these,approaches,have,succeeded,resuming,many,prudent,strategies,should,applied,individuals,according,specific,etiology,by,balancing,benefits,potential,risks,This,also,discusses,how,can,induced,immunization,against
AB值:
0.654977
相似文献
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。